353 related articles for article (PubMed ID: 14978246)
41. The mechanism of action of multidrug-resistance-linked P-glycoprotein.
Sauna ZE; Smith MM; Müller M; Kerr KM; Ambudkar SV
J Bioenerg Biomembr; 2001 Dec; 33(6):481-91. PubMed ID: 11804190
[TBL] [Abstract][Full Text] [Related]
42. Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6).
Cai J; Daoud R; Alqawi O; Georges E; Pelletier J; Gros P
Biochemistry; 2002 Jun; 41(25):8058-67. PubMed ID: 12069597
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes.
Sauna ZE; Ambudkar SV
J Biol Chem; 2001 Apr; 276(15):11653-61. PubMed ID: 11154703
[TBL] [Abstract][Full Text] [Related]
44. MRP1 and its role in anticancer drug resistance.
Lu JF; Pokharel D; Bebawy M
Drug Metab Rev; 2015; 47(4):406-19. PubMed ID: 26541366
[TBL] [Abstract][Full Text] [Related]
45. Drug resistance caused by multidrug resistance-associated proteins.
Wijnholds J
Novartis Found Symp; 2002; 243():69-79; discussion 80-2, 180-5. PubMed ID: 11990783
[TBL] [Abstract][Full Text] [Related]
46. Molecular basis of multidrug transport by ATP-binding cassette transporters: a proposed two-cylinder engine model.
van Veen HW; Higgins CF; Konings WN
J Mol Microbiol Biotechnol; 2001 Apr; 3(2):185-92. PubMed ID: 11321572
[TBL] [Abstract][Full Text] [Related]
47. Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein.
Taylor AM; Storm J; Soceneantu L; Linton KJ; Gabriel M; Martin C; Woodhouse J; Blott E; Higgins CF; Callaghan R
Br J Pharmacol; 2001 Dec; 134(8):1609-18. PubMed ID: 11739236
[TBL] [Abstract][Full Text] [Related]
48. Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux.
Morrow CS; Peklak-Scott C; Bishwokarma B; Kute TE; Smitherman PK; Townsend AJ
Mol Pharmacol; 2006 Apr; 69(4):1499-505. PubMed ID: 16434618
[TBL] [Abstract][Full Text] [Related]
49. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity.
Conseil G; Perez-Victoria JM; Jault JM; Gamarro F; Goffeau A; Hofmann J; Di Pietro A
Biochemistry; 2001 Feb; 40(8):2564-71. PubMed ID: 11327879
[TBL] [Abstract][Full Text] [Related]
50. Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1.
Hou Y; Cui L; Riordan JR; Chang X
J Biol Chem; 2000 Jul; 275(27):20280-7. PubMed ID: 10781583
[TBL] [Abstract][Full Text] [Related]
51. Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport.
Yang R; Chang XB
Biochim Biophys Acta; 2007 Feb; 1768(2):324-35. PubMed ID: 17187755
[TBL] [Abstract][Full Text] [Related]
52. RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance.
Perez-Victorias FJ; Conseil G; Munoz-Martinez F; Perez-Victoria JM; Dayan G; Marsaud V; Castanys S; Gamarro F; Renoir JM; Di Pietro A
Cell Mol Life Sci; 2003 Mar; 60(3):526-35. PubMed ID: 12737312
[TBL] [Abstract][Full Text] [Related]
53. Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.
Kern A; Szentpétery Z; Liliom K; Bakos E; Sarkadi B; Váradi A
Biochem J; 2004 Jun; 380(Pt 2):549-60. PubMed ID: 14759224
[TBL] [Abstract][Full Text] [Related]
54. Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1.
Nabekura T; Yamaki T; Ueno K; Kitagawa S
Biochem Biophys Res Commun; 2008 May; 369(2):363-8. PubMed ID: 18280247
[TBL] [Abstract][Full Text] [Related]
55. Drug binding domains of MRP1 (ABCC1) as revealed by photoaffinity labeling.
Karwatsky JM; Georges E
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):19-30. PubMed ID: 14754409
[TBL] [Abstract][Full Text] [Related]
56. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism.
Loo TW; Clarke DM
J Natl Cancer Inst; 2000 Jun; 92(11):898-902. PubMed ID: 10841824
[TBL] [Abstract][Full Text] [Related]
57. Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans.
Willyerd FA; Empey PE; Philbrick A; Ikonomovic MD; Puccio AM; Kochanek PM; Okonkwo DO; Clark RS
J Neurotrauma; 2016 Jan; 33(2):226-31. PubMed ID: 25891836
[TBL] [Abstract][Full Text] [Related]
58. Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.
Holló Z; Homolya L; Hegedûs T; Müller M; Szakács G; Jakab K; Antal F; Sarkadi B
Anticancer Res; 1998; 18(4C):2981-7. PubMed ID: 9713496
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation.
Wilson MW; Fraga CH; Fuller CE; Rodriguez-Galindo C; Mancini J; Hagedorn N; Leggas ML; Stewart CF
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1269-73. PubMed ID: 16565357
[TBL] [Abstract][Full Text] [Related]
60. An ABC transporter with a secondary-active multidrug translocator domain.
Venter H; Shilling RA; Velamakanni S; Balakrishnan L; Van Veen HW
Nature; 2003 Dec; 426(6968):866-70. PubMed ID: 14685244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
